Free Trial
NASDAQ:PLRZ

Polyrizon 3/25/2026 Earnings Report

Polyrizon logo
$14.28 +0.14 (+0.95%)
As of 11:59 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Polyrizon EPS Results

Actual EPS
$2.81
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Polyrizon Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Polyrizon Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Polyrizon Earnings Headlines

Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses an emerging potential $10 trillion technology backed by Elon Musk and Sam Altman. This breakthrough could completely replace our need for foreign oil - and send one small group of stocks soaring in the process.tc pixel
Polyrizon (NASDAQ:PLRZ) Upgraded to Hold at Wall Street Zen
See More Polyrizon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Polyrizon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Polyrizon and other key companies, straight to your email.

About Polyrizon

Polyrizon (NASDAQ:PLRZ) is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

View Polyrizon Profile